Cita APA

Chen, X., Cai, C., Yu, M., Feng, Z., Zhang, Y., Liu, P., . . . Yu, C. (2019). LB100 ameliorates nonalcoholic fatty liver disease via the AMPK/Sirt1 pathway. World J Gastroenterol.

Citación estilo Chicago

Chen, Xue-Yang, Chang-Zhou Cai, Meng-Li Yu, Ze-Min Feng, Yu-Wei Zhang, Pei-Hao Liu, Hang Zeng, y Chao-Hui Yu. "LB100 Ameliorates Nonalcoholic Fatty Liver Disease Via the AMPK/Sirt1 Pathway." World J Gastroenterol 2019.

Cita MLA

Chen, Xue-Yang, et al. "LB100 Ameliorates Nonalcoholic Fatty Liver Disease Via the AMPK/Sirt1 Pathway." World J Gastroenterol 2019.